4.5
慢性阻塞性肺疾病 I: 简介
慢性阻塞性肺疾病，即 COPD，是一种常见、可预防且可治疗的呼吸系统疾病，其特征为持续性症状和进行性气流受限。这种受限由小气道疾病，即阻塞性细支气管炎，以及肺实质破坏，即肺气肿，共同导致，二者均由暴露于有害颗粒物或气体所引发的慢性炎症驱动。
该疾病包括两种主要病理实体：肺气肿，其特征为肺泡壁破坏和弹…
慢性阻塞性肺疾病（COPD）是一种常见、可预防且可治疗的肺部疾病。该病具有持续性呼吸系统症状和气流受限，通常由长期暴露于有害颗粒物或气体引起，导致慢性炎症和肺组织损伤。
在慢性阻塞性肺疾病（COPD）中，慢性炎症会导致气道和肺泡发生持久性改变。这些改变可能包括影响肺泡的肺气肿，以及部分患者出现的慢性支气管炎征象，如咳嗽和黏液过多。
主要危险因素包括烟草烟雾、职业性接触粉尘和化学烟雾，以及在通风不良的居所中使用生物燃料烹饪和取暖导致的室内空气污染。
其他风险包括结核病或肺炎等反复发生的儿童呼吸道感染。
一个重要的遗传因素是α-1抗胰蛋白酶缺乏症，该疾病会损害肺部对抗蛋白水解酶的能力，导致组织损伤加速，并增加早发性慢性阻塞性肺疾病（COPD）的风险。
View the full transcript and gain access to JoVE Core videos
Q1: What causes chronic obstructive pulmonary disease?
COPD results from long-term exposure to harmful particles or gases causing chronic inflammation and lung damage. Major risk factors include tobacco smoke, occupational dust and chemical fumes, indoor air pollution from biomass fuels, and infections like tuberculosis or repeated childhood pneumonia. Genetic factors, particularly alpha-1 antitrypsin deficiency, also increase susceptibility to early-onset COPD.
Q2: How does chronic inflammation damage the lungs in COPD?
Chronic inflammation causes lasting structural changes in airways and air sacs. These changes include emphysema, which destroys alveolar walls and reduces elastic recoil, and chronic bronchitis, characterized by airway inflammation and excess mucus production. Together, these pathological processes limit airflow and impair gas exchange.
Q3: What is the difference between emphysema and chronic bronchitis in COPD?
Emphysema involves destruction of alveolar walls and loss of elastic recoil in air sacs. Chronic bronchitis is defined by chronic cough and sputum production due to airway inflammation and mucus hypersecretion. Although distinct in origin, these conditions often coexist in COPD patients and together contribute to airflow limitation.
Q4: Why is alpha-1 antitrypsin deficiency a genetic risk factor for COPD?
Alpha-1 antitrypsin is a protective enzyme that counteracts proteolytic enzymes in the lungs. Deficiency of this protein impairs the lungs' ability to defend against tissue-damaging enzymes, leading to accelerated lung damage and increased risk of early-onset emphysema even with minimal environmental exposure.
Q5: How do occupational and environmental exposures contribute to COPD development?
Long-term occupational exposure to dust such as silica and cotton, and chemical fumes, damages lung tissue over time. Indoor air pollution from biomass fuels in poorly ventilated homes and urban air pollution also increase COPD risk. These exposures accumulate gradually, leading to progressive lung damage and airflow limitation.
Q6: What role do early-life factors play in COPD susceptibility?
Early-life factors including recurrent respiratory infections, poor lung development from prematurity, and childhood asthma increase susceptibility to COPD later in life. These conditions may compromise initial lung development and function, making individuals more vulnerable to subsequent environmental exposures and chronic inflammation.
Q7: Is COPD preventable and treatable?
Yes, COPD is preventable and treatable. It is a common lung disorder characterized by persistent respiratory symptoms and airflow limitation. Prevention focuses on avoiding harmful exposures like tobacco smoke and occupational hazards, while treatment aims to manage symptoms and slow disease progression.